Magdalena E. Sobieszczyk

13.6k total citations · 3 hit papers
93 papers, 4.3k citations indexed

About

Magdalena E. Sobieszczyk is a scholar working on Infectious Diseases, Epidemiology and Virology. According to data from OpenAlex, Magdalena E. Sobieszczyk has authored 93 papers receiving a total of 4.3k indexed citations (citations by other indexed papers that have themselves been cited), including 74 papers in Infectious Diseases, 43 papers in Epidemiology and 20 papers in Virology. Recurrent topics in Magdalena E. Sobieszczyk's work include HIV/AIDS Research and Interventions (46 papers), HIV, Drug Use, Sexual Risk (25 papers) and HIV Research and Treatment (20 papers). Magdalena E. Sobieszczyk is often cited by papers focused on HIV/AIDS Research and Interventions (46 papers), HIV, Drug Use, Sexual Risk (25 papers) and HIV Research and Treatment (20 papers). Magdalena E. Sobieszczyk collaborates with scholars based in United States, United Kingdom and South Africa. Magdalena E. Sobieszczyk's co-authors include Jason Zucker, Christine J. Kubin, Neil W. Schluger, Yifei Sun, Joshua D. Geleris, George Hripcsak, Matthew R. Baldwin, Jonathan Platt, R. Graham Barr and Daniel K. Manson and has published in prestigious journals such as Nature, New England Journal of Medicine and Journal of Clinical Investigation.

In The Last Decade

Magdalena E. Sobieszczyk

88 papers receiving 4.2k citations

Hit Papers

Observational Study of Hydroxychloroquine in Hospitalized... 2020 2026 2022 2024 2020 2022 2022 250 500 750 1000
What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

  1. Observational Study of Hydroxychloroquine in Hospitalized Patients with Covid-19
    2020 1.1k citations Jason Zucker, Christine J. Kubin et al. profile →
  2. Antibody evasion properties of SARS-CoV-2 Omicron sublineages
    2022 478 citations Sho Iketani, Lihong Liu et al. Nature profile →
  3. Antibody evasion by SARS-CoV-2 Omicron subvariants BA.2.12.1, BA.4 and BA.5
    2022 433 citations Qian Wang, Yicheng Guo et al. Nature profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Magdalena E. Sobieszczyk United States 25 3.3k 909 855 514 291 93 4.3k
Hongzhou Lu China 33 2.6k 0.8× 747 0.8× 606 0.7× 613 1.2× 508 1.7× 236 4.6k
Jason Zucker United States 28 2.5k 0.8× 942 1.0× 859 1.0× 346 0.7× 191 0.7× 133 3.8k
Hongzhou Lu China 27 3.5k 1.1× 1.3k 1.5× 1.1k 1.2× 742 1.4× 175 0.6× 187 6.5k
Neeltje van Doremalen United States 27 4.5k 1.4× 676 0.7× 782 0.9× 662 1.3× 85 0.3× 60 6.3k
SeyedAhmad SeyedAlinaghi Iran 34 1.6k 0.5× 823 0.9× 414 0.5× 163 0.3× 206 0.7× 246 3.2k
Müge Çevik United Kingdom 26 2.2k 0.7× 533 0.6× 357 0.4× 277 0.5× 105 0.4× 65 3.5k
Pyoeng Gyun Choe South Korea 32 3.3k 1.0× 1.1k 1.2× 387 0.5× 345 0.7× 103 0.4× 168 4.5k
Amanda Cohn United States 30 1.3k 0.4× 2.1k 2.3× 365 0.4× 284 0.6× 232 0.8× 84 4.5k
Hilary D. Marston United States 17 1.3k 0.4× 538 0.6× 252 0.3× 359 0.7× 156 0.5× 24 2.8k

Countries citing papers authored by Magdalena E. Sobieszczyk

Since Specialization
Citations

This map shows the geographic impact of Magdalena E. Sobieszczyk's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Magdalena E. Sobieszczyk with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Magdalena E. Sobieszczyk more than expected).

Fields of papers citing papers by Magdalena E. Sobieszczyk

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Magdalena E. Sobieszczyk. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Magdalena E. Sobieszczyk. The network helps show where Magdalena E. Sobieszczyk may publish in the future.

Co-authorship network of co-authors of Magdalena E. Sobieszczyk

This figure shows the co-authorship network connecting the top 25 collaborators of Magdalena E. Sobieszczyk. A scholar is included among the top collaborators of Magdalena E. Sobieszczyk based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Magdalena E. Sobieszczyk. Magdalena E. Sobieszczyk is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
2.
Heck, Craig J., Katharine Kripke, Sergio Torres‐Rueda, et al.. (2024). Leveraging international stakeholders’ experiences with oral PrEP costs to accelerate implementation of the monthly dapivirine vaginal ring: A qualitative study. Health Research Policy and Systems. 22(1). 156–156. 1 indexed citations
3.
Bowen, Anthony, Jason Zucker, Yanhan Shen, et al.. (2022). Reduction in Risk of Death Among Patients Admitted With COVID-19 Between the First and Second Epidemic Waves in New York City. Open Forum Infectious Diseases. 9(9). ofac436–ofac436. 1 indexed citations
4.
Iketani, Sho, Lihong Liu, Yicheng Guo, et al.. (2022). Antibody evasion properties of SARS-CoV-2 Omicron sublineages. Nature. 604(7906). 553–556. 478 indexed citations breakdown →
5.
Wang, Qian, Yicheng Guo, Sho Iketani, et al.. (2022). Antibody evasion by SARS-CoV-2 Omicron subvariants BA.2.12.1, BA.4 and BA.5. Nature. 608(7923). 603–608. 433 indexed citations breakdown →
6.
7.
Cohen, Taylor S., Elizabeth J. Kelly, Sven Nylander, et al.. (2022). Serum levels of anti-PF4 IgG after AZD1222 (ChAdOx1 nCoV-19) vaccination. Scientific Reports. 12(1). 7961–7961. 5 indexed citations
8.
9.
May, Michael, Michelle Chang, Donald Dietz, et al.. (2021). Limited Utility of Procalcitonin in Identifying Community-Associated Bacterial Infections in Patients Presenting with Coronavirus Disease 2019. Antimicrobial Agents and Chemotherapy. 65(4). 36 indexed citations
10.
Kubin, Christine J., Thomas H. McConville, Donald Dietz, et al.. (2021). Characterization of Bacterial and Fungal Infections in Hospitalized Patients With Coronavirus Disease 2019 and Factors Associated With Health Care-Associated Infections. Open Forum Infectious Diseases. 8(6). ofab201–ofab201. 103 indexed citations
11.
Laracy, Justin, Jason Zucker, Delivette Castor, et al.. (2021). HIV-1 Infection Does Not Change Disease Course or Inflammatory Pattern of SARS-CoV-2-Infected Patients Presenting at a Large Urban Medical Center in New York City. Open Forum Infectious Diseases. 8(2). ofab029–ofab029. 12 indexed citations
12.
Zucker, Jason, Caroline Carnevale, Delivette Castor, et al.. (2021). Attitudes and Perceived Barriers to Routine HIV Screening and Provision and Linkage of Postexposure Prophylaxis and Pre-Exposure Prophylaxis Among Graduate Medical Trainees. AIDS Patient Care and STDs. 35(5). 180–187. 13 indexed citations
13.
Phipps, Meaghan, Luis H. Barraza, Elijah LaSota, et al.. (2020). Acute Liver Injury in COVID‐19: Prevalence and Association with Clinical Outcomes in a Large U.S. Cohort. Hepatology. 72(3). 807–817. 235 indexed citations
14.
Zucker, Jason, Benjamin Patterson, Susan Olender, et al.. (2018). Missed Opportunities for Engagement in the Prevention Continuum in a Predominantly Black and Latino Community in New York City. AIDS Patient Care and STDs. 32(11). 432–437. 18 indexed citations
15.
Meyers, Kathrine, Kristina Rodriguez, Yumeng Wu, et al.. (2017). Lessons for Patient Education Around Long-Acting Injectable PrEP: Findings from a Mixed-Method Study of Phase II Trial Participants. AIDS and Behavior. 22(4). 1209–1216. 26 indexed citations
16.
Markowitz, Martin, Ian Frank, Robert M. Grant, et al.. (2017). Safety and tolerability of long-acting cabotegravir injections in HIV-uninfected men (ECLAIR): a multicentre, double-blind, randomised, placebo-controlled, phase 2a trial. The Lancet HIV. 4(8). e331–e340. 164 indexed citations
17.
Frahm, Nicole, Stephen C. De Rosa, Christina Ochsenbauer, et al.. (2014). CD8 + T-cell Mediated HIV Inhibition after Vaccination with a DNA/Recombinant Ad5 (rAd5) HIV Vaccine Is Similar to that Seen in Treated HIV Infection. AIDS Research and Human Retroviruses. 30(S1). A84–A84. 1 indexed citations
18.
Sobieszczyk, Magdalena E., et al.. (2014). A Forgotten Population: Older Adults with Newly Diagnosed HIV. AIDS Patient Care and STDs. 28(10). 530–536. 37 indexed citations
19.
Janes, Holly, Peter B. Gilbert, Susan Buchbinder, et al.. (2013). In Pursuit of an HIV Vaccine: Designing Efficacy Trials in the Context of Partially Effective Nonvaccine Prevention Modalities. AIDS Research and Human Retroviruses. 29(11). 1513–1523. 15 indexed citations
20.
Tieu, Hong‐Van, Morgane Rolland, Scott M. Hammer, & Magdalena E. Sobieszczyk. (2013). Translational Research Insights From Completed HIV Vaccine Efficacy Trials. JAIDS Journal of Acquired Immune Deficiency Syndromes. 63(Supplement 2). S150–S154. 3 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Hongzhou Lu Breakdown of academic impact, for papers by Jason Zucker Breakdown of academic impact, for papers by Hongzhou Lu Breakdown of academic impact, for papers by Neeltje van Doremalen Breakdown of academic impact, for papers by SeyedAhmad SeyedAlinaghi Breakdown of academic impact, for papers by Müge Çevik Breakdown of academic impact, for papers by Pyoeng Gyun Choe Breakdown of academic impact, for papers by Amanda Cohn Breakdown of academic impact, for papers by Hilary D. Marston
Rankless by CCL
2026